Trial Profile

A Phase 0 Clinical Trial of Two Candidate Azoles (Ketoconazole and Posaconazole) for Patients With Recurrent High Grade Glioma

Status: Not yet recruiting

Phase of Trial: Phase 0

Latest Information Update: 14 Mar 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ketoconazole (Primary) ; Posaconazole (Primary)
Indications Glioma
Focus Pharmacokinetics; Proof of concept

Most Recent Events

07 Mar 2024 Planned End Date changed from 1 Aug 2022 to 1 Jun 2027.
07 Mar 2024 Planned primary completion date changed from 1 Aug 2022 to 1 Jun 2025.
07 Mar 2024 Planned initiation date changed from 1 May 2019 to 1 Jun 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com